Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Balloon Valvuloplasty Device Market In 2029?

The market size for balloon valvuloplasty devices has seen robust growth recently. It’s projected to expand from $2.44 billion in 2024 to $2.59 billion in 2025, with a compound annual growth rate (CAGR) of 6.0%. The growth experienced in past years is due to several factors such as the rise in healthcare spending, enlargement of healthcare facilities, heightened awareness and diagnostic skills, preference for ambulatory care settings, advancements in telemedicine increasing accessibility, and a focus on enhancing patients’ quality of life.

What Growth Rate Is Forecasted for the Balloon Valvuloplasty Device Market by 2029?

The market for balloon valvuloplasty devices is projected to experience robust growth in the coming years, escalating to $3.23 billion by 2029 with a compound annual growth rate (CAGR) of 5.7%. This expected surge during the forecast period can be linked to the rising incidence of heart valve diseases among the aging global population, the growing preference for less invasive methods of treating heart valve problems, quick approvals and clearances for innovative balloon valvuloplasty devices, and an emphasis on economically efficient healthcare solutions. Noteworthy trends to look out for in the forecast period consist of improved imaging techniques for accurate diagnosis, customized medical treatment strategies, increased funding for research and development, evolution of regenerative methods in cardiovascular disease treatment, and the assimilation of digital health technologies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17090&type=smp

Which Key Companies Are Shaping the Future of the Balloon Valvuloplasty Device Market?

Major companies operating in the balloon valvuloplasty device market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Philips Healthcare, Becton Dickinson Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Biotronik SE & Co. KG, Integer Holdings Corporation, LivaNova PLC, Cordis Corporation, NuMED Inc., Pfm Medical GmbH, Tokai Medical Products Inc, Translumina GmbH, Meril Life Sciences Pvt. Ltd., Toray Medical Company Limited, QT Vascular Ltd.

Which Factors Are Driving Demand in the Balloon Valvuloplasty Device Industry?

The growth of the balloon valvuloplasty device market is predicted to be bolstered by an increasing preference for minimally invasive procedures. This refers to medical techniques executed via small incisions or natural body openings, which hasten recovery times and lessen trauma compared with conventional surgeries. There is an uptick in demand for minimally invasive procedures due to the benefits such as shorter recovery periods, diminished risk of complications, and decreased post-surgery pain relative to traditional operations. Balloon valvuloplasty devices, which are deployed in minimally invasive surgeries to expand constricted heart valves, improve blood circulation, and alleviate symptoms, are in demand. For example, in January 2024, Intuitive Surgical Inc., an American producer of robotic products, stated that they had installed 415 da Vinci surgical systems, which employ a minimally invasive surgical technique, in the final quarter of 2023. This signifies a 12% rise in comparison to 2022. As a consequence, the escalating preference for minimally invasive procedures is catalyzing the growth of the balloon valvuloplasty device market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=17090&type=smp

How Is the Balloon Valvuloplasty Device Market Segmented by Several Divisions?

The balloon valvuloplasty device market covered in this report is segmented –

1) By Product Type: Standard Balloon, Cutting Balloon, Scoring Balloon, High-Pressure Balloon, Low-Pressure Balloon

2) By Age Group: Pediatric, Adult

3) By End-use: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End Uses

Subsegments:

1) By Standard Balloon: Non-Compliant Balloons, Compliant Balloons

2) By Cutting Balloon: Single-Cutting Balloon, Multi-Cutting Balloon

3) By Scoring Balloon: Single-Score Balloons, Dual-Score Balloons

4) By High-Pressure Balloon: Non-Compliant High-Pressure Balloons, Compliant High-Pressure Balloons

5) By Low-Pressure Balloon: Semi-Compliant Low-Pressure Balloons, Non-Compliant Low-Pressure Balloons

What are the Emerging Market Trends Driving the Growth of the Balloon Valvuloplasty Device Industry?

Top-tier corporations in the balloon valvuloplasty device sector are concentrating their efforts on the creation of sophisticated items like Pacing Guidewires to establish a stronger foothold within the industry. Pacing guidewires, which are used during procedures for temporary cardiac pacing, help keep the heart’s rhythm steady as the balloon catheter is inserted and inflated to expand the constricted valve. For instance, Teleflex Incorporated, a medical device firm based in the United States, was granted approval by the FDA in June 2023 for their product, the Wattson Temporary Pacing Guidewire. This instrument was specially created to assist during transcatheter aortic valve replacement (TAVR) and balloon aortic valvuloplasty (BAV) procedures. The Wattson Temporary Pacing Guidewire is multi-functional, aiding in both valve delivery and ventricular bipolar pacing during these structural heart surgeries. With its adaptable distal pigtail form, numerous electrodes, and bipolar design, it’s constructed to minimize ventricular perforation risk while ensuring dependable electrical capture during swift pacing.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/balloon-valvuloplasty-device-global-market-report

Which Regions Are Driving Growth in the Balloon Valvuloplasty Device Market?

North America was the largest region in the balloon valvuloplasty device market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the balloon valvuloplasty device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17090

This Report Delivers Insight On:

1. How big is the balloon valvuloplasty device market, and how is it changing globally?

2. Who are the major companies in the balloon valvuloplasty device market, and how are they performing?

3. What are the key opportunities and risks in the balloon valvuloplasty device market right now?

4. Which products or customer segments are growing the most in the balloon valvuloplasty device market?

5. What factors are helping or slowing down the growth of the balloon valvuloplasty device market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model